Atlas Trials

CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

Clinical trial NCT05306288 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05306288
Sponsor
Delfi Diagnostics Inc.
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer
Start date
2022-04-07
Primary completion
2026-06-30
Enrollment
11935

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.